# A Study of the Use of Chartis System to Optimize Subject Selection for Endobronchial Lung Volume Reduction (ELVR)

> **NCT01101958** · NA · COMPLETED · sponsor: **Pulmonx Corporation** · enrollment: 96 (actual)

## Conditions studied

- Emphysema

## Interventions

- **DEVICE:** Chartis System
- **DEVICE:** Endobronchial Valve (EBV) Treatment

## Key facts

- **NCT ID:** NCT01101958
- **Lead sponsor:** Pulmonx Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-01
- **Primary completion:** 2013-03
- **Final completion:** 2013-03
- **Target enrollment:** 96 (ACTUAL)
- **Last updated:** 2017-05-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01101958

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01101958, "A Study of the Use of Chartis System to Optimize Subject Selection for Endobronchial Lung Volume Reduction (ELVR)". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01101958. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*